RIV Capital Inc (RIV.CX)
0.13
0.00 (0.00%)
CAD |
CNSX |
May 17, 16:00
RIV Capital Total Liabilities (Quarterly): 215.27M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 215.27M |
| June 30, 2023 | 211.12M |
| March 31, 2023 | 206.85M |
| December 31, 2022 | 206.54M |
| September 30, 2022 | 258.28M |
| June 30, 2022 | 345.70M |
| March 31, 2022 | 126.69M |
| December 31, 2021 | 121.84M |
| September 30, 2021 | 118.32M |
| June 30, 2021 | 2.112M |
| March 31, 2021 | 23.99M |
| Date | Value |
|---|---|
| December 31, 2020 | 36.82M |
| September 30, 2020 | 26.72M |
| June 30, 2020 | 1.533M |
| March 31, 2020 | 2.106M |
| December 31, 2019 | 2.157M |
| September 30, 2019 | 6.084M |
| June 30, 2019 | 9.672M |
| March 31, 2019 | 11.09M |
| December 31, 2018 | 6.476M |
| September 30, 2018 | 18.50M |
| March 31, 2018 | 16.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.533M
Minimum
Jun 2020
345.70M
Maximum
Jun 2022
106.77M
Average
77.57M
Median
Total Liabilities (Quarterly) Benchmarks
| Biocure Technology Inc | 0.3732M |
| Core One Labs Inc | 1.759M |
| Nova Mentis Life Science Corp | 0.6549M |
| Nanosphere Health Sciences Inc | 2.088M |
| Lobe Sciences Ltd | 3.343M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 340.84M |
| Shareholders Equity (Quarterly) | 125.57M |
| Debt to Equity Ratio | 1.119 |
| Current Ratio | 18.40 |
| Net Debt Paydown Yield | -17.01% |